Literature DB >> 16901378

Treatment considerations in neuropathic pain.

Raphael J Leo1.   

Abstract

Neuropathy is a relatively common source of acute and chronic pain. Emerging evidence suggests several pathophysiological mechanisms underlying the neuropathic pain associated with various disorders. Antidepressants and anticonvulsants have largely been the mainstay of treatment. Pharmacologic treatment of neuropathy frequently requires use of multiple medications. Ideally, the selection of which medications to use should be based on targeting the multiple pathophysiologic mechanisms contributing to neuropathic pain transmission. Psychological variables may play a role in predisposing patients to chronic neuropathy after acute illness. In addition, comorbid conditions, especially depression, can complicate the presentation, clinical course, and response to treatment of patients with chronic pain. Treatment of depression may be essential to fully enlist the chronic neuropathic pain patient in comprehensive pain management and rehabilitative approaches.

Entities:  

Year:  2006        PMID: 16901378     DOI: 10.1007/s11940-006-0028-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  72 in total

Review 1.  Status of current clinical trials in diabetic polyneuropathy.

Authors:  V Bril
Journal:  Can J Neurol Sci       Date:  2001-08       Impact factor: 2.104

Review 2.  Anticonvulsants in neuropathic pain: rationale and clinical evidence.

Authors:  Troels S Jensen
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

Review 3.  Psychological aspects of neuropathic pain.

Authors:  J A Haythornthwaite; L M Benrud-Larson
Journal:  Clin J Pain       Date:  2000-06       Impact factor: 3.442

4.  Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats.

Authors:  Hideaki Obata; Dawn Conklin; James C Eisenach
Journal:  Pain       Date:  2005-02       Impact factor: 6.961

5.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

6.  Treatment of diabetic neuropathic pain with gabapentin alone or combined with vitamin B complex. preliminary results.

Authors:  Roberto Medina-Santillán; Guadalupe Morales-Franco; Judith Espinoza-Raya; Vinicio Granados-Soto; Gerardo Reyes-García
Journal:  Proc West Pharmacol Soc       Date:  2004

7.  Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study.

Authors:  M S Wallace; S Magnuson; B Ridgeway
Journal:  Reg Anesth Pain Med       Date:  2000 Sep-Oct       Impact factor: 6.288

Review 8.  CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy.

Authors:  Aaron Vinik
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

9.  Clinical characteristics and economic costs of patients with painful neuropathic disorders.

Authors:  Ariel Berger; Ellen M Dukes; Gerry Oster
Journal:  J Pain       Date:  2004-04       Impact factor: 5.820

10.  Hypnotherapy for reflex sympathetic dystrophy.

Authors:  M J Gainer
Journal:  Am J Clin Hypn       Date:  1992-04
View more
  2 in total

1.  Tricyclic Antidepressant and/or γ-Aminobutyric Acid-Analog Use Is Associated With Fall Risk in Diabetic Peripheral Neuropathy.

Authors:  Amanda C Randolph; Yu-Li Lin; Elena Volpi; Yong-Fang Kuo
Journal:  J Am Geriatr Soc       Date:  2019-01-29       Impact factor: 5.562

2.  Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial.

Authors:  Mahsa Sedighi; Ali Haghnegahdar
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.